Table 2.

Relative risks of cancer progression for low, intermediate and high risk cancer compared to all localised prostate cancer patients in the SPCG-4 study

Relative risk	Risk group	Mean	SE	Distribution
In the radical prostatectomy arm
RR_lowrisk_WW	Low risk	0.2947	0.0100	Gamma
RR_intermrisk_WW	Intermediate risk	1.0397	0.0347	Gamma
RR_highrisk_WW	High risk	1.9600	0.0655	Gamma
In the watchful waiting arm
RR_lowrisk_RP	Low risk	0.3006	0.0107	Gamma
RR_intermrisk_RP	Intermediate risk	1.0606	0.0374	Gamma
RR_highrisk_RP	High risk	1.9993	0.0703	Gamma

RR relative risk, RP radical prostatectomy, AS active surveillance, WW watchful waiting RR_lowrisk_WW: relative risk of cancer progression for low risk patients compared to localised prostate cancer patients in the watchful waiting arm